MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
0.6483
+0.0262 (4.21%)
At close: Nov 12, 2026, 4:00 PM EST
0.6600
+0.0117 (1.80%)
After-hours: Nov 12, 2026, 6:02 PM EST
MIRA Pharmaceuticals Market Cap
MIRA Pharmaceuticals has a market cap or net worth of $27.24 million as of November 12, 2026. It is the 34,744th most valuable company in the world and the 5,003rd biggest in the United States. Its market cap has decreased by 9.76% in one year.
Market Cap
27.24M
Enterprise Value
19.13M
1-Year Change
-9.76%
Global Rank
Country Rank
#5,003 United States
Category
ChartMarket Cap Chart
Since the IPO on August 3, 2023, MIRA Pharmaceuticals's market cap has decreased from $103.22M to $27.24M, a decrease of -73.61%. That is a compound annual growth rate of -33.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 27.24M | -56.92% |
| Dec 31, 2025 | 63.23M | 234.93% |
| Dec 31, 2024 | 18.88M | 21.65% |
| Dec 29, 2023 | 15.52M | -84.96% |
| Aug 3, 2023 | 103.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pfizer | 167.18B |
| Bristol-Myers Squibb Company | 127.80B |
| Sanofi | 115.66B |
| GSK plc | 102.05B |
| Biogen | 37.53B |
| Grifols | 7.58B |
| Organon & Co. | 3.64B |
| Amarin Corporation | 249.09M |